Raymond James Financial Services Advisors’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-15,821
| Closed | -$161K | – | 3243 |
|
|
2021
Q1 | $161K | Buy |
+15,821
| New | +$161K | ﹤0.01% | 2946 |
|
|
2020
Q4 | – | Sell |
-12,703
| Closed | -$44K | – | 2952 |
|
|
2020
Q3 | $44K | Buy |
+12,703
| New | +$44K | ﹤0.01% | 2760 |
|
|
2019
Q1 | – | Sell |
-28,703
| Closed | -$232K | – | 2759 |
|
|
2018
Q4 | $232K | Buy |
+28,703
| New | +$232K | ﹤0.01% | 2161 |
|
|
2016
Q4 | – | Sell |
-12,883
| Closed | -$57K | – | 2315 |
|
|
2016
Q3 | $57K | Sell |
12,883
-8,200
| -39% | -$36.3K | ﹤0.01% | 2185 |
|
|
2016
Q2 | $60K | Buy |
21,083
+7,100
| +51% | +$20.2K | ﹤0.01% | 2145 |
|
|
2016
Q1 | $40K | Buy |
+13,983
| New | +$40K | ﹤0.01% | 1955 |
|